celecoxib has been researched along with B-Cell Lymphoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, M | 1 |
| Wang, L | 1 |
| Ni, M | 1 |
| Neuber, B | 1 |
| Wang, S | 1 |
| Gong, W | 1 |
| Sauer, T | 1 |
| Schubert, ML | 1 |
| Hückelhoven-Krauss, A | 1 |
| Xia, R | 1 |
| Ge, J | 1 |
| Kleist, C | 1 |
| Eckstein, V | 1 |
| Sellner, L | 1 |
| Müller-Tidow, C | 1 |
| Dreger, P | 1 |
| Schmitt, M | 1 |
| Schmitt, A | 1 |
| Paul, AG | 1 |
| Chandran, B | 1 |
| Sharma-Walia, N | 1 |
| Gallouet, AS | 1 |
| Travert, M | 1 |
| Bresson-Bepoldin, L | 1 |
| Guilloton, F | 1 |
| Pangault, C | 1 |
| Caulet-Maugendre, S | 1 |
| Lamy, T | 1 |
| Tarte, K | 1 |
| Guillaudeux, T | 1 |
| Wun, T | 1 |
| McKnight, H | 1 |
| Tuscano, JM | 1 |
4 other studies available for celecoxib and B-Cell Lymphoma
| Article | Year |
|---|---|
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
Topics: Antigens, CD19; Apoptosis; Aspirin; Celecoxib; Cell Proliferation; Coculture Techniques; Cyclooxygen | 2021 |
Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Celecoxib; Cell Line, Tum | 2013 |
COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis.
Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Celecoxib; Cell Cycle; Cell Line, Tumor; C | 2014 |
Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma.
Topics: Apoptosis; B-Lymphocytes; Celecoxib; Cell Division; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygena | 2004 |